Image credit: Thomas Deerinck/NCMIR/Science Source
A team of researches have developed and tested a drug to treat Alzheimer’s disease. It was tested on mice and results were very encouraging. The new drug mitigates symptoms and also increases life span in patients by the weakening disease. The results and finding have been published in the Journal of Clinical Investigation.
Professor Andrew Tobin said that the drug is meant to target a specific protein called M1 muscarinic receptor, associated with the disease. It activates the protein, thereby improving cognition. Although there were similar drugs developed, they had various unfavorable side effects making them obsolete.
However, the drug used in the latest set of tests did not cause any adverse side effects on the subjects. Professor Tobin and Dr. Sophie have learnt that these can both slow down brain degeneration, such as cognitive decline and also increase the life span of these terminally sick nice.
Will it work on humans?
The tests have been performed only on animals and therefore, there is no evidence that these will have the same effects on human. If it does not deliver on its promise, it might still pave way to other significant discoveries in the research ahead.
Currently, treatments can only mask or relieve the patients off their symptoms. The cure has not been found but every new research project is a step towards finding it.
Scientists aim to create treatments that can both improve symptoms and slow down the detrimental progress of the disease. It might take a few more years to find the cure but the increasing pool of knowledge will always be useful.